Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.
Researchers discover neural mechanism behind leptin resistance and a way to reverse it
Worldwide obesity rates have more than doubled since 1990, with nearly a billion people now falling into the category.